Open Label Extension Study of tDCS Plus Guided Imagery for Women With

Status Withdrawn

Clinical Trial Summary

This is an open label extension study trial of tDCS with a standardized guided imagery intervention. Up to 20 women with chronic pelvic pain, who completed participation in the initial randomized trial (IRB 2019-362) will be enrolled. Subjects will complete 5 tDCS treatments with guided imagery and a 1-week follow-up visit.

Clinical Trial Description

Chronic pelvic pain (CPP) is a common and often debilitating in women. It occurs below the umbilicus and is severe enough to cause functional impairment or require treatment. Transcranial Direct Stimulation (tDCS) is a non-invasive brain stimulation technique. As tDCS modulates nerve activity and connectivity, it is also expected to cause measurable changes in brain activity. Guided imagery is a form of hypnosis using words to direct one's thoughts and attention to imagined sensations. Guided imagery has demonstrated efficacy in reducing pain related to many conditions including cancer pain, chronic lower back pain, and post-operative pain. More information is needed to evaluate the effects of tDCS and guided imagery in the treatment of chronic pelvic pain. This study consists of one screening visit, 5 study intervention visits, and a 1-week follow-up visit. After obtaining informed consent, study staff will assess for changes in medical history an pelvic pain treatments since the end of participation in Part 1 (IRB 2019-362). Urine will be collected for urinalysis and a urine pregnancy test will be collected for women of childbearing potential. If urinalysis and pregnancy test are negative, subjects will complete questionnaires, vitals, and a baseline EEG will be conducted. At the 5 interventional visits, transcranial direct stimulation (tDCS) with guided imagery will be delivered. A EEG will be completed after the 1st and 5th treatment visits. At each visit questionnaires will be administered and urine pregnancy test, if the woman is of childbearing potential. At the 1-week follow- up visit, an EEG will be performed, questionnaires administered. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04252040
Study type	Interventional
Source	William Beaumont Hospitals
Contact
Status	Withdrawn
Phase	N/A
Start date	March 2020
Completion date	November 17, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03638856` - Comparing Effectiveness of Oral Misoprostal for Cervical Priming in Hysteroscopy	N/A
Withdrawn	`NCT03272360` - Endometriosis Biomarker Discovery Study	N/A
Completed	`NCT01020162` - Treatment of Ilioinguinal Entrapment Syndrome - an Often Overlooked Cause of Chronic Pelvic Pain	N/A
Recruiting	`NCT05836454` - The Soft Tissue Mobilization Techniques on PMS	N/A
Completed	`NCT02372903` - Efficacy of Palmitoylethanolamide-polydatin Combination on Chronic Pelvic Pain in Patients With Endometriosis	N/A
Recruiting	`NCT05185180` - Effects of Epigenetic Regulation in Chronic Pelvic Pain Syndrome
Recruiting	`NCT05970783` - A Study of Jincaopian Tablets on Chronic Pelvic Pain After Pelvic Inflammatory Disease	Phase 3
Completed	`NCT04615247` - Program to Overcome Pelvic Pain Study	N/A
Completed	`NCT02721108` - Mindfulness Meditation for Chronic Pelvic Pain Management	N/A
Not yet recruiting	`NCT00844012` - Continuous Postoperative Use of Low-Dose Combined Oral Contraceptivesfor for Endometriosis-Related Chronic Pelvic Pain	Phase 4
Recruiting	`NCT04976751` - Real World Study on the Application of Appropriate Electrophysiological Technology in the Diagnosis and Treatment of Andrology Diseases in Northwest China	Phase 1
Completed	`NCT01802528` - Clinical Effectiveness of Obturator Externus Muscle Injection in Chronic Pelvic Pain Patients	N/A
Completed	`NCT03175809` - Pelvic Floor Muscles Training Associated Dry Needling for Chronic Pelvic Pain	N/A
Recruiting	`NCT05324280` - Acupuncture in a Multidisciplinary Approach for Vulvodynia and Chronic Pelvic Pain	N/A
Not yet recruiting	`NCT02556411` - Comparison of Estrogen-progestin Therapy in Continuous Regimen Versus Combination Estrogen-progestin Therapy in Continuous Regimen Plus Levonorgestrel-releasing Intrauterine System (LNG-IUS)	N/A
Completed	`NCT04104542` - MOCHI: An RCT of Mindfulness as Treatment for Chronic Pelvic Pain in AD Women	N/A
Completed	`NCT01553201` - Botulinum Toxin for Pelvic Pain in Women With Endometriosis	Phase 1/Phase 2
Completed	`NCT03617627` - Self-management Program in Chronic Pelvic Pain	N/A
Recruiting	`NCT06019091` - Optimal Frequency Used in Transcutaneous Electrical Nerve Stimulation (TENS) for Treating Pelvic Pain in Adults	N/A
Terminated	`NCT03541954` - Neurophysiological Validation of the Clinical Criteria of Sensitization in Chronic Pelvic and Perineal Pain Population	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Open Label Extension Study of tDCS Plus Guided Imagery for Women With Chronic Pelvic Pain (CPP)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms